Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||UNKNOWN / 1||- / OT|
Administered by: Other Purchased by: ??
Symptoms: Drug ineffective, Dyspnoea, Pyrexia, Blood test, COVID-19, SARS-CoV-2 test positive, SARS-CoV-2 test, SARS-CoV-2 antibody test positive
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data: Test Date: 20210301; Test Name: Blood test; Result Unstructured Data: Test Result:non immunological response in terms of creation of; Comments: non immunological response in terms of creation of special antibodies against epitope S, zero number of antibodies; Test Date: 20210305; Test Name: COVID-19 antibody test positive; Result Unstructured Data: Test Result:POSITIVE RT - PCR; Test Date: 20210305; Test Name: Covid-19 rapid antigen test; Result Unstructured Data: Test Result:positive; Test Date: 20210305; Test Name: Covid-19 RT-PCR test; Result Unstructured Data: Test Result:positive; Test Date: 20210305; Test Name: COVID-19 PCR test positive; Result Unstructured Data: Test Result:POSITIVE
CDC 'Split Type': GRPFIZER INC2021358077
Write-up: covid-19; covid-19; Fever; Dyspnea; This is a spontaneous report from a contactable physician downloaded from the regulatory authority. The regulatory authority number is GR-GREOF-20211741. An 87-year-old male patient received BNT162B2 (COMIRNATY; Lot Number: Unknown), dose 2 intramuscular on 24Feb2021 as single dose and the first dose on an unspecified date for covid-19 immunization. The patient''s medical history and concomitant medications were not reported. On 05Mar2021, the patient experienced fever and dyspnea and covid-19 on 08Mar2021. The events were serious as they lead to death. The patient underwent lab tests and procedures which included blood test on 01Mar2021, showed non immunological response in terms of creation of special antibodies against epitope S, zero number of antibodies, COVID-19 antibody test was positive (reported as positive RT-PCR) on 05Mar2021, Covid-19 rapid antigen test: positive on 05Mar2021, Covid-19 RT-PCR test: positive on 05Mar2021, COVID-19 PCR test positive: positive on 05Mar2021. Details were as follows: The patient completed the vaccination on 24Feb2021. He was in contact with a positive case and showed symptoms of fever and dyspnea. Positive RT-PCR and rapid antigen on 05Mar2021. He stayed at home and died suddenly in his sleep on 08Mar2021. From blood taken before the illness from Covid-19 ( March 1) IgG and IgM antibodies were measured (clia detects IgG antibodies against S protein, including the epitope of the S1 - receptor binding (RBD) region. Antibodies and vaccines against this epitope, were neutralized and zero. Patient with polypharmacy (per os every medication), for unspecified chronic diseases. The cause of death was from Covid-19. No biopsy was performed. Finally, the blood tests performed on 01Mar2021, showed zero number of antibodies as the doctor explained. The relatedness of drug to reactions fever and dyspnea per source of assessment, regulatory authority 14/03/2021: Method of assessment: WHO GLOBAL INTROSPECTION METHOD was reported as unlikely. The patient died on 08Mar2021. An autopsy was not performed. Sender Comment: Initial report with follow up information. No Follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Covid-19
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166